| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.48 | 0.09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |